Header cover image

Investing Ideas
/
Australian Pharmaceuticals & Biotech Pure Equity Growth

Australian Pharmaceuticals & Biotech Pure Equity Growth

Results

6

0 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

6 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	CUV Clinuvel Pharmaceuticals	AU$14.36	-3.3%	-3.5%	AU$716.0m	AU$29.29	PE20.1x	E27.4%	0.3%
	CUV Clinuvel Pharmaceuticals	AU$14.30	-3.4%	-4.0%	AU$716.0m	AU$29.17	PE20.1x	E27.4%	0.3%
	BOT Botanix Pharmaceuticals	AU$0.38	-1.9%	216.7%	AU$689.3m	n/a	PS333.1x	E99.4%	n/a
	BOT Botanix Pharmaceuticals	AU$0.38	-2.6%	216.7%	AU$689.3m	n/a	PS333.1x	E99.4%	n/a
	GSS Genetic Signatures	AU$0.67	-2.2%	28.8%	AU$152.0m	AU$1.10	PS11x	E98.6%	n/a
	GSS Genetic Signatures	AU$0.67	-4.3%	27.9%	AU$152.0m	AU$1.09	PS11x	E98.6%	n/a

Page 1 of 1